WA
ABBV icon

WPG Advisers’s AbbVie ABBV Stock Holding History

WPG Advisers’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$99.4K Buy
395
+75
+23% +$16.1K 0.06% 194
2026
Q1 		$69.6K Sell
320
-6
-2% -$1.33K 0.05% 209
2025
Q4 		$74.5K Sell
326
-88
-21% -$20K 0.06% 217
2025
Q3 		$95.9K Buy
414
+4
+1% +$815 0.07% 171
2025
Q2 		$76.1K Sell
410
-81
-16% -$15.1K 0.06% 199
2025
Q1 		$103K Sell
491
-14
-3% -$2.72K 0.1% 159
2024
Q4 		$89.7K Buy
+505
New +$92.8K 0.08% 190

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WPG Advisers's ABBV Position: Q2 2026 in Review

WPG Advisers increased its AbbVie (ABBV) stake by 23% in Q2 2026, buying an estimated $16.1K and bringing the position to 395 shares worth $99.4K. The position accounts for 0.06% of the portfolio, ranked #194.

WPG Advisers first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $103K in Q1 2025. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • WPG Advisers held 395 shares of AbbVie worth $99.4K as of Q2 2026.
  • WPG Advisers bought 75 AbbVie shares in Q2 2026, an estimated $16.1K.
  • AbbVie made up 0.06% of WPG Advisers's portfolio in Q2 2026, its #194 holding.
  • WPG Advisers first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • WPG Advisers's AbbVie position peaked at $103K in Q1 2025.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.